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Abstract
Secretory component (SC), a glycoprotein associated with polymeric IgA
and IgM (pIg) in external secretions, is produced by certain epithelial
cells and is thought to be the receptor mediating the transcellular tran­
sport of pIg. We studied the biosynthesis and processing of rabbit and hu­
man SC. Using translation of mRNA from rabbit mammary gland and liver in a
cell-free system supplemented with dog pancreas microsomal vesicles, we
discovered that the translation products of rabbit SC include at least four
polypeptides. Moreover, we found that all four polypeptides are syn-
thesized not as soluble secretory forms, but as larger transmembrane forms
that are core glycosylated and asymmetrically integrated into the dog pan­
creas microsomal vesicles with an 11-15 kilodalton domain remaining in the
cytoplasm. We studied the biosynthesis and processing of human SC in a
cell-free translations and pulse labelling of cells, SC is made as a single
larger precursor with an approximately 15 kilodalton cytoplasmic domain.
In pulse-chase experiments, the carbohydrate moieties of the precursor are
first converted to the complex type and the precursor is then proteolyti­
cally cleaved to a form slightly larger than SC isolated from colostrum.
This cleaved form is slowly released from the cell. Partial NH2-terminal
sequencing indicates that the cleaved form of SC is derived from the NH2-
terminal, ectoplasmic (non-cytoplasmic) domain of the precursor.
To determine the structure of the cytoplasmic and membrane spanning
portions of the SC precursor, we cloned and sequenced DNA complementary to
1563 nucleotides at the 3' end of rabbit SC mRNA, and deduced the
corresponding sequence of the COOH-terminal 163 amino acid residues of the
SC precursor. The SC precursor has a putative membrane spanning segment of
-2-
23 non-charged amino acid residues, followed by a cytoplasmic tail of 103




Polymeric IgA and IgM (pIg) are specifically taken up by a variety of
glandular epithelial cells and transported across the cell into external
secretions, such as milk, bile, and intestinal fluid, where they form the
first immunological defense against infection (1). During this transport,
the epithelial cell adds an extra polypeptide, secretory component (SC) to
the pIg (2, 3). It has long been supposed that SC somehow mediates the
transcellular transport of pIg and, in fact, one of the earliest reports on
SC called it "transport piece" (4).
Brandtzaeg first proposed that SC was the receptor for pIg at the
basolateral surface of the epithelial cell (5). He found SC at this sur­
face in intestinal epithelial cells (6) and this observation has been ex­
tended to epithelial cells in other tissues (7-9). pIg can bind to this
basolateral (or in hepatocytes, sinusoidal) cell surface-associated SC
(10-18). The SC-pIg complex formed there is then transported to the apical
(or in hepatocytes, bile canalicular) surface where the complex is released
into the secretion. The binding and transport of pIg can be blocked by ad­
ding either excess soluble SC or antibodies to sc (14-18). Antibodies to SC
can even replace pIg and be transported into secretions (16).
On the basis of cytochemical, cell fractionation, and pIg uptake stu­
dies, the pathways of SC and pIg in the cell have been shown to be unusual­
ly complex (9, 15-23). SC is synthesized in the rough endoplasmic reticu­
lum (RER), transported through the Golgi apparatus, and to the basolateral
cell surface. Here it binds pIg, and the SC-pIg complex is endocytosed via
clathrin coated pits. However, unlike most instances of receptor-mediated
endocytosis (24, 25), the ligand is not degraded in lysosomes. Rather the
SC-pIg complex is rapidly carried in vesicles across the cell, exocytosed
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at the apical surface, and discharged into the secretion. This process of
receptor-mediated transcytosis is an attractive model system for studying
general aspects of protein traffic and sorting in the cell.
A second remarkable aspect of SC is its apparent dual character. SC
functions first as a plasma membrane receptor for pIg. Normally such re­
ceptors are integral membrane proteins which are anchored in the lipid bi­
layer by a hydrophobic portiones) and are generally not soluble in water in
the absence of detergents. Yet SC isolated from secretions is hydrophilic
and water-soluble.
One explanation, proposed by Kuhn and Kraehenbuhl, is that SC is
secreted by cells and is bound to an unidentified membrane receptor on the
cell surface (22, 26). SC would then act as a linker between this uniden­
tified receptor and the pIg. In support of this model, they found high­
affinity binding sites for SC on the surface of mammary cells. However,
such sites were not found on liver cells and this was attributed to en­
dogenous receptor occupancy.
As a result of our cell-free translation experiments (Chapter 3) we
proposed (27) that SC was not made as a soluble, secreted protein, but
rather as a transmembrane precursor (Fig. 1). When this precursor reaches
the basolateral surface, a portion of the precursor, the ectoplasmic
domain, is exposed on the outside of the cell and constitutes the ligand
(pIg) binding domain. This domain is subsequently cleaved off from the
remainder of the precursor and thus becomes the "mature" SC found in secre­
tions. Cleavage probably occurs either in the endocytotic vesicle or after
exocytosis. The cytoplasmic portion of the precursor may act as an effec­
tor domain and serve to guide the SC precursor through the cell. The ulti­
mate fate of the membrane spanning and cytoplasmic portions of the precur-
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sor after cleavage are unknown; presumably they are rapidly degraded.
Our model is similar to that first proposed by Brandtzaeg (5), except
that it distinguishes between the transmembrane precursor of SC and the
proteolytically generated, secreted form of SC.
Much of the work described in this dissertation has been directed to­
wards testing predictions of this model. Three basic approaches were used.
First, we studied the earliest steps in the biosynthesis of SC by cell-free
translations of rabbit SC mRNA (21). Mature rabbit SC consists of a group
of several polypeptides and we found four primary translation products.
More importantly, we were able to show in a cell-free coupled translation
and membrane insertion system that these SC precursors are transmembrane
proteins, each of which have sizable (approximately 15 kilodaltons) cyto­
plasmic domains. As discussed in Chapter 6, this cytoplasmic domain may
interact with other proteins in the cytoplasm and provide the information
for guiding SC in its long pathway through the cell.
Second, we studied the complete process of biosynthesis, cleavage, and
release of SC in a human colon cancer-derived cell line (28). These cells
have been shown to transport pIg and SC in the "normal" manner (23). Humans
have only one form of mature SC and we found one primary translation pro­
duct. In pulse chase experiments, a core-glycosylated form in the RER is
first observed. As in the rabbit, this form has a cytoplasmic domain of
about 15 kilodaltons. After conversion of its carbohydrate moieties to the
complex type, the precursor is proteolytically cleaved to a form which is
slightly larger than authentic SC isolated from colostrum. This cleaved
form is then slowly released from the cell. Direct protein sequencing in­
dicated that mature SC is derived from the NH2-terminal, ectoplasmic domain
of the precursor.
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Finally, we investigated the primary structure of the cytoplasmic and
membrane spanning portions of the se precursor. As mentioned above, the
cytoplasmic domain may contain the information for guiding the se precursor
through the cell. Determining its primary structure is therefore a first
step towards elucidating the mechanisms involved in protein sorting in the
cell. We cloned complementary DNA (cDNA) to se mRNA and isolated a plasmid
containing sequences corresponding to 1563 bases at the 3' end of se mRNA.
We sequenced the cDNA and found a 489 base open reading frame at the 5' end
of this sequence which codes for 163 amino acids at the eOOH-terminus of
the se precursor. The protein sequence contains a stretch of 23 non-polar
amino acid residues which is likely to be a membrane spanning segment. The
proposed cytoplasmic tail comprises 103 amino acid residues, with a
preponderance of charged and hydrophilic residues.
-7-
Figure 1
Hypothetical model for the intracellular pathway of SC in � glandular cell.
The luminal or apical portion of the plasma membrane (upper half) is
separated from the basolateral region of the plasma membrane (lower half)
by the junctional complex (JC). In parenchymal liver cells, the bile
canalicular region of the plasma membrane corresponds to the apical sur­
face, and the sinusoidal region of the plasma membrane is equivalent to the
basolateral region. SC is synthesized by membrane-bound polysomes as a
transmembrane formes) and is cotranslationally and asymmetrically integrat­
ed into the rough endoplasmic reticulum (step 1). A distinct ectoplasmic
domain (open circle) is translocated into the rough endoplasmic reticulum
lumen, another distinct cytoplasmic domain (solid circle) remains un­
translocated, and a membrane-spanning segment(s) (bar) links the two
domains. After transport to the Golgi complex (step 2), and subsequently
to the basolateral region of the plasma membrane (step 3), the ectoplasmic
domain of the SC binds to pIg (step 4). The transmembrane SC-pIg complex
is then removed from the basolateral region of the plasma membrane via en­
docytosis (step 5). The endocytotic vesicle traverses the cell and fuses
with the apical region of the plasma membrane (step 6). The ectoplasmic
domain of transmembrane SC is endoproteolytically cleaved (step 7), most
likely either in the endocytotic vesicle or at the apical surface, generat­
ing a soluble SC-pIg complex and a membrane bound remainder of transmem­
brane SC that includes the cytoplasmic domain and transmembrane
segments(s). Various different intermediate transmembrane forms of SC
resulting from sequential proteolytic or other modifications during its in­
tracellular pathway may exist. Our model is similar to that proposed by
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Brandtzaeg (5) except that it distinguishes between the larger, intracellu­
lar transmembrane form(s) of SC and the smaller, proteolytically generated,










SC purified from rabbit milk, as well as goat antiserum to this SC,
were the gift of J.-P. Kraehenbuhl (22). Goat antiserum to rabbit secreto­
ry IgA was purchased from Cappel Laboratories, Oowington, PA. and immu­
noprecipitated the same SC primary translation products as the antiserum
provided by Kraehenbuhl.
Human colostral secretory IgA was obtained initially as a generous
gift from Or. C. Cunningham-Rundles, Sloan Kettering Institute for Cancer
Research, and was later purchased from Sigma, St. Louis, Mo., and Cappel
Laboratories,
To purify human SC for use as an immunogen, 50 mg of human colostral
secretory IgA (Sigma) was dissolved in 10 ml of 70� formic acid. 250 mg
CNBr was added, and the sample digested for two hr at room temperature.
Since human SC contains no methionine (29), it was not attacked by the
CNBr, while contaminating methionine containing proteins were digested to
smaller fragments. The reaction was diluted with 10 volumes of H20, lyo­
philized, and the products subjected to preparative sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SOS-PAGE) on 5-10� polyacrylam­
ide gradient slab gels (30). The gels were stained with Coomassie blue for
five min and the SC band was cut out. One-fifth of the total gel slice was
homogenized with 4 ml H20 and 6 ml complete Freund's adjuvant. The homogen­
ate was injected subcutaneously into 15 sites on the back of a female New
Zealand white rabbit. Booster injections using the same amount of antigen
in incomplete Freund's adjuvant were given 4 and 6 weeks later. The rabbit
was bled 2 weeks after the second boost.
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Affinity purified antibodies to human SC were used to immunoprecipi­
tate SC precursor synthesized in the cell-free translation system (see
below). SC was purified by gel electrophoresis as described above and
electroeluted from the gel. Approximately 2 mg SC was coupled to CNBr-
Sepharose according to the manufacturer's instructions. The serum was
passed over the column and specific antibodies were eluted with 0.1 M
glycine-HCI, pH 2.3, and immediately adjusted to pH 7.5 with Tris base.
Commercial rabbit· anti-human SC antisera were from Dako (Accurate Chemi­
cals, Hicksville, N.Y.); Boehringer Mannheim, Indianapolis, Ind.; Atlantic
Antibodies, Scarborough, Me.; and Behring Diagnostics, Sommerville, N.J.
All of these commercial antisera recognized human SC, although their titers
against SDS-denatured SC was lower than that of the antiserum prepared in
this study.
2.2 Cell-Free Synthesis and Analysis of Rabbit SC.
Cell-free translation of SC. Total cellular RNA was extracted by the
SDS/proteinase K/phenol/chloroform/isoamyl alcohol method (31) from rabbit
liver and lactating mammary gland. Two New Zealand White rabbits were
used. Rabbit A (mammary gland only) was from Cunicentre (Jongny, Switzer­
land); the mammary gland was shipped frozen to New York. Rabbit B (mammary
gland and liver) was from Dutchland Laboratories, Denver, PA. In certain
experiments mRNA was further purified by selection of poly (A)-containing
strands on oligo(dT)-cellulose (32), and size fractionation on a sucrose
gradient (33). The wheat germ extract used for cell-free translation ex­
periments was prepared as described previously (34). RNA was included at a
final concentration of 0.2 mg/ml. Translations were generally in a volume
of 0.02 ml, unless otherwise specified. A radioactive amino acid, usually
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[35S]cysteine, was included at a final concentration of 1 mCi/ml.
Membrane Integration of SC. Dog pancreas microsomal vesicles were
prepared as described (35). When specified, they were included in the
cell-free translation reaction at a final concentration of 2 A260 units/mI.
(1 A260 unit is that amount which has an absorbance of at 260 nm when
contained in a volume of 1 ml and measured with a pathlength of cm.) In
certain experiments, after the synthesis was completed, the mixture was
adjusted to 2 mM in CaC12, using a 100 mM stock, and 0.1 volumes of 3 mg/ml
trypsin was added. The reaction was incubated on ice for 1 hr.
Immunoprecipitation and Product Analysis. After these reaction were
completed, SDS was added to 2� and the samples were heated to 1000C for 5
min, cooled, and diluted with 4 volumes of 2.5% Triton X-IOO/150 mM NaCl/20
mM triethanolamine-HCl, pH 8.1/5 mM EDTA/1% Trasylol. Antiserum to rabbit
SC was added to a final concentration of 0.1 % and the samples were kept at
40C for 16 hrs. Protein A-Sepharose was added to a concentration of 1% and
the samples agitated for 1 hr. The beads were then washed with six 1.4 ml
portions of 1� Triton X-100/0.2� SOS/150 mM NaCl/20 mM triethanolamine-HCl,
pH 8.1/5 mM EOTA/0.1� Trasylol, and once with the same buffer lacking
detergents. After removal of all of the final wash buffer, 0.02 ml of
loading buffer (5� SOS/0.2M Tris base/1 M dithiothreitol/ 0.3 M
sucrose/0.002� bromophenol blue) was added and the samples incubated at
1000C for 5 min. The samples were then analyzed by SOS-PAGE on gels con­
taining a 5-10% linear gradient of polyacrylamide (30). Gels were general­
ly impregnated with diphenyloxazole (36) and exposed to Kodak XAR-5 film at
_700 for 5-60 days.
Binding of Cell-Free Synthesized SC to Con !-Sepharose. Cell-free
translations (0.1 ml) were carried out in the presence of microsomal vesi-
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cles. SOS was added to 2� and the sample incubated at 1000c for 5 min.
The sample was then diluted with 4 volumes of 2.5� Triton X-IOO/150 mM
NaCl/1 mM MgC12/20 mM triethanolamine-HCl, pH 7.5. Con A-Sepharose (0.2 ml
of beads) was then added and the sample agitated at 220C for 3 hrs. The
beads were then washed with twelve 1.4 ml portions of 0.05� SOS/150 mM
NaCl/20 mM triethanolamine-HCl, pH 7.5. Bound proteins were eluted by ad-
ding 0.1 ml of 1 � SOS and boiling for 5 min. The eluate was immunoprecip-
itated as described above. As a control for non-specific binding, the same
experiment was performed, except that incubation with the beads was carried
out in the presence of 0.4 M alpha-methyl mannoside.
Sequencing of Tryptic Peptides of Cell-Free Synthesized SC. A ml
cell-free synthesis was carried out, using [35S]methionine as the labeled
amino acid. The reaction was immunoprecipitated and products analyzed by
SOS-PAGE. The gel was dried directly onto 3MM paper and exposed to Kodak
XAR-5 film. The film was aligned with the gel by spotting radioactive ink
on the gel before exposure. The M =90,000 band of precursor SC was ex­r
cised with a razor blade. The band was incubated in 0.2 ml of 0.1� SOS for
2 days at 370C. An equal volume of 0.2� Triton X-IOO as well as 0.06 mg of
trypsin were added and the incubation continued for 2 more days. The su-
pernatant above the gel slice was then loaded directly into the reaction
cup of a Beckman 890C sequenator and sequenced (37).
Binding of Cell-Free Synthesized SC Precursors to IgA-Sepharose.
Purified polymeric, J chain-containing, human myeloma IgA was kindly pro-
vided by J. M. McCune, Rockefeller Univ. This IgA was coupled to CNBr-
Sepharose according to the manufacturer's directions, using a final concen-
tration of 1 mg protein/g Sepharose. Translations (0.1 ml) were performed
in the presence of microsomal membranes. After translation was completed,
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the membranes were recovered from the translation mixture by layering the
mixture in a Beckman Airfuge tube over a two-step sucrose gradient consist-
ing of 0.08 ml of 0.5 M sucrose and 0.025 ml of 2 M sucrose. Both sucrose
solutions also contained 150 mM NaCl and 20 mM Na phosphate (pH 6.5).
After centrifugation for 15 min at 160,000 x �, the membranes were
recovered at the 0.5 M/2 M interface in a volume of 0.025 mI. They were
diluted to 0.2 ml with 150 mM NaCl/20 mM Na phosphate, pH 6.5, and adjusted
to 1 � in Triton X-100. One per cent of this material was analyzed direct-
ly by SDS-PAGE and fluorography. To the remaining 99� of the material,
0.02 ml of IgA-Sepharose was added and the samples agitated at 40C for 16
hrs. The beads were washed five times wih 1.2 ml of 1� Triton X-100/150 mM
NaCl/20mM Na phosphate, pH 6.5. Bound proteins were eluted by boiling with
loading buffer, and the samples analyzed by SDS-PAGE and fluorography.
_g.l Synthesis of SC by the Cell Line, HT29.
Cell culture. The cell line HT29, originally derived from a human
colon adenocarcinoma, was obtained from Dr. J. Fogh, Sloan Kettering Insti-
tute for Cancer Research. Cells were maintained as previously described
(38) in McCoy's 5a medium, supplemented with 10� fetal bovine serum, 100
units/ml penicillin, 100 ug/ml streptomycin, and 2.5 ug/ml fungizone.
Cell-free translation. Cells from eight 100 mm dishes were scraped
off with a rubber policeman in a minimal volume of phosphate-buffered sa-
line (PBS, 150 mM NaCl/20 mM Na phosphate, pH 7.4). After a brief centri­
fugation, the pellet was frozen and kept at _800 until used. Total RNA was
prepared as described above for rabbit tissues. It was translated in the
wheat germ cell-free system in a volume of 0.1 mI. In indicated experi-
ments, dog pancreas microsomes were included in the translation and the
-14-
reaction scaled up to 0.4 ml; in some cases the translation products were
post-translationally digested with trypsin. Translation products were im­
munopreciptated with affinity purified antiserum to human SC, and analyzed
by SDS-PAGE and fluorography.
Pulse-chase experiments. Cells in 35 mm dishes were rinsed twice with
PBS. Cells were starved for 20 min with minimal essential media (MEM)
made without cysteine and supplemented with 10� dialysed fetal bovine
serum. This was replaced with 0.3 ml of the same media containing 0.05 mCi
[35S]cysteine and the cells were pulsed for various periods. In chase ex­
periments the labelling media was then removed, the cells washed with PBS,
and 0.8 ml McCoy's 5a medium supplemented with serum and antibiotics (which
contains a >1000 fold excess of cold cysteine) was added. At various time
points the cells and media were havested by adding 0.5 ml of 0.5� SDS/150
mM NaCI/20 mM triethanolamine-HCI, pH B.1. The cells were scraped off of
the plate using a rubber policeman, and the lysate transferred to a 1.5 ml
centrifuge tube. The tube was placed in a boiling water bath for 5 min.
Lysis of the cells with SDS, followed immediately by boiling, was used to
prevent artifactual proteolysis (32). After cooling, the sample was soni­
cated for 20 sec with a Branson sonicator at a power setting of 4, using a
microprobe. The sample was then diluted with an equal volume of Triton di­
lution buffer. Immunoprecipitation was then carried out as described as
above, using 4 ul of anti-SC per 35 mm dish. In some experiments, immu­
noprecipitated products were treated with endoglycosidase H prior to elec­
trophoresis (40,41).
Proteolytic digestion of cell homogenate. A 60 mm dish of cells was
pulse-labeled for 30 min. The media was removed and the monolayer washed 3
times with ice-cold 0.25 M sucrose/5 mM N-2-hydroxyethylpiperazine-N'-2-
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ethanesulfonic acid (pH adjusted to 1.4 with KOH). The monolayer was
scraped off in 0.5 ml of this buffer with a rubber policeman and
transferred to a 1 ml Oounce homogenizer (Wheaton Glass) with a tight fit­
ting ("A") pestle. After 20 strokes on ice the homogenate was divided into
0.1 ml aliquots. Certain samples received pronase (final concentration
0.02 mg/ml) and/or Triton X-IOO (final concentration 0.4S). Samples were
incubated on ice for 1 hr. Reactions were terminated by boiling for 5 min,
followed by solubilization with SOS (IS final concentration) and immunopre­
cipitation.
Partial amino-terminal sequence analysis of products. In each of the
amino-terminal sequencing experiments, cells were grown in four to eight 60
mm dishes. Labelling for the isoleucine experiment was done with MEM made
up without isoleucine; the proline experiments used MEM containing all
essential amino acids. Each dish was labeled with 0.65 ml of media con­
taining 0.25 mCi of tritiated amino acid for 30 min. In certain experi­
ments, after the 30 min labelling, cells were chased for 24 hr. Where in­
dicated, cells were homogenized after labelling and then digested with
pronase. Products for sequencing were immunoprecipitated, separated by
SOS-PAGE, eluted from the gel, and sequenced as previously described (31).
Cloning of HT29 cell line. In preliminary labelling experiments using
the HT29 line, the amount of SC which could be immunoprecipitated from the
cells was rather low. Since previous reports (11, 23, 38) indicated that
not all of of the cells were positive for SC (as assayed by immunofluores­
cence) it seemed likely that the HT29 line was a mixed population of cells.
We therefore isolated individual clones and screened them for production of
SC. A single cell suspension was prepared by trypsinization, diluted to
1-2 cells/ml, and 0.1 ml aliquots were placed in the wells of three 98 well
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microtiter plates. A mixture of fresh and conditioned McCoy's 5a medium
was used. Wells were inspected to insure that none contained 2 or more
cells. After 3 months, the colonies were transferred to 25 cm2 flasks, and
after a further 2-3 months a portion of the cells in each clone were
transferred to 35 mm dishes. Twelve clones were isolated in this way.
These were pulse-labeled with [35S]cysteine and the SC precursor immunopre-
cipitated and analyzed as above. Interestingly, all 12 of the clones syn-
thesized some SC precursor; however there was a considerable variation in
the amount produced. Two of the clones produced equally large amounts of
SC precursor, and one of these, HT29.E10, was selected for further study.
It should be pointed out that in preliminary studies using the uncloned
HT29 line, the same pulse-chase and translation results reported here were
obtained, except that the amount of SC precursor synthesized was less.
2.4 Recombinant DNA Methods.
Construction of � cDNA library from �artially purified SC mRNA. As
described above, mRNA was prepared from rabbit lactating mammary gland and
the mRNA was size selected on a sucrose gradient. Fractions enriched in
mRNA coding for the M =90-93,000 SC polypeptides were identified by in vi-r -- ---
tro translation. The first and second strands of cDNA were synthesized by
standard methods (42) with reverse transcriptase, using 5 ug of partially
purified SC mRNA in an initial reaction volume of 100 ul. The hairpin loop
was then cleaved with S1 nuclease (42). The double stranded cDNA was sized
on a sucrose gradient and material sedimenting faster than approximately
500 base pairs was collected (42). Approximately 10-20 residues of dCTP
were then added to the 3' ends using terminal deoxynucleotidyltransferase
(42). The tailed molecules were annealed to PBR 322 which had been digest-
-17-
ed with Pst 1 and tailed with 10-20 dGMP residues. The molecules were then
transformed into E. coli cells, strain MCI061 (42), and spread onto tetra­
cycline containing plates. About 600 tetracycline resistant, ampicillin
sensitive clones resulted.
Identification of clones coding for SC. Eighteen clones were grown in
individual 250 ml cultures, amplified with chloramphenicol, and the plasmid
DNAs extracted (43) and purified by banding on CsCl ethidium bromide densi­
ty gradients (44). Hybrid selected translation was performed by the method
of Ricciardi (45). Ten ug of plasmid DNA was cut with Eco R1 and bound to
cm diameter nitrocellulose filters. The filters were hybridized with 20
ug of total rabbit liver or mammary RNA. After extensive washing to remove
unbound RNA, the specifically bound material was removed by boiling for 90
sec with 400 ul of H20. The eluted mRNA was ethanol precipitated with 5 ug
of carrier wheat germ tRNA, and translated as previously described in the
wheat germ cell-free translation system. The translation products were im­
munoprecipitated with antiserum to rabbit secretory IgA (which recognizes
rabbit SC) and the products analyzed by SDS-PAGE and fluorography. One of
these initial clones specifically selected mRNAs for all of the SC transla­
tion products. Its insert was cut out by digestion with Pst 1, purified by
agarose gel electrophoresis (46), nick translated (47), and used as a probe
in a colony hybridization screen of the remainder of the cDNA library (48).
Twelve additional clones were thus identified, and the largest (p32.23) had
an insert of approximately 1650 nucleotides, including poly(A) and
poly(G)-poly(C) tails.
Agarose � electrophoresis and nitrocellulose blot analysis of SC
mRNAs. One ug of total poly(A) containing mRNA from rabbit liver and lac­
tating mammary gland was fractionated on a l� agarose gel containing 2.2 M
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formaldehyde (49). Gels were stained with ethidium bromide to visualize
the ribosomal RNA molecular weight markers. The separated mRNAs were then
transferred to nitrocellulose, and the filters baked in a vacuum oven at
800C for 2 hrs. The filters were prehybridized for 3 hrs at 420 C in 15 ml
of 50 � formamide/1 M NaCl/50 mM Na phosphate (pH 1.0)/ 10 mM EDTA/ 0.5�
SDS/ 0.2� bovine serum albumin/0.2 � ficoll/0.2 � polyvinyl pyrrolidone/
mM Na4 pyrrophosphate. One million cpm of nick-translated p32.23 was then
added to the reaction, and the incubation continued for 16 hrs. The
filters were then washed in three changes of 500 ml each of 50 mM NaCl/lO
mM NaPi (pH 1.0) at 500C over a period of 2 hrs, and then exposed for 2




We used the method of randomly subcloning restriction
DNA into the phages M13 Mp8 and Mp9 and sequencing the
resultant subclones by the dideoxy chain termination technique using a
universal M13 sequencing primer (50-53). Sequencing gels were 40 cm long,
30 cm wide, 0.4 mm thick, and contained 5.5� acrylamide/0.215� bis­
acrylamide/8M urea. Running buffer was 0.1 M boric acid/0.1 M Tris base/2
mM Na2EDTA. Gels were run at 43 watts for 2-10 hrs, dried onto 3MM paper,
and exposed to either Fuji RX or Kodak SB-5 film at room temperature. To
sequence through the G-C tail at the 5' end of the molecule, we substituted
reverse transcriptase for the Klenow fragment of DNA polymerase 1 (54).
This method did not work on the G-C tail at the 3' end of the insert, and
so 63 bases, or 4� of the the total 1563 bases, were sequenced in only one
direction. DNA sequence analysis was by the computer programs of Staden
(55), as implemented at the Rockefeller University computer facility.
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Materials.
[35S]methionine, [35S]cysteine, [3H]proline, and [3H]isoleucine were
the highest specific activities available from New England Nuclear.
[3H]dCTP (specific activity 25 Ci/mMole) and [32P]alpha-dATP (specific ac­
tivity 800 Ci/mMole) were also from New England Nuclear. McCoy's 5A and
minimal essential media, fetal bovine serum, penicillin, streptomycin,
fungizone and phosphate-buffered saline (PBS) were from Gibco, Grand Is­
land, N.Y. 98-well microtitre plates were from Flow Laboratories, Mclean,
Va. Streptomyces griseus endo-beta-N-acetylglucosaminidase H (endoglycosi­
dase H, EC 3.2.1.96) was the kind gift of Dr. P. Robbins, MIT. Pronase was
from Boehringer Mannheim. Trypsin, pretreated with L-(tosylamido-2-
phenyl)ethyl chloromethyl ketone, was from Worthington. Trasylol (aproti­
nin) was from Mobay Chemical, New York. Restriction enzymes were either
from New England Biolabs, Beverly, MA., or Bethesda Research Laboratories,
Bethesda, MD., and were used according to the manufacturers' instructions.
Avian myeloblastosis virus reverse transcriptase was provided by J. Beard,
Life Sciences, Inc., St. Petersburg, FL. Aspergillus oryzae S1 nuclease
and the 15 base oligonucleotide universal sequencing primer were from
Bethesda Research Labs. Deoxynucleotides and dideoxynucleotides were from
PL Biochemicals. �. coli DNA polymerase 1, as well as its Klenow fragment,
were from Boehringer Mannheim, Indianapolis, IN. Terminal deoxynucleo­
tidyltransferase, and Pst 1 cut and oligo-dG tailed plasmid PBR 322 were
from New England Nuclear, Boston MA.. Nitrocellulose filters, type BA85,
were from Schleicher and Schuell, Keene, NH. �. coli strain MC1061 was the
kind gift of K. Knight, Univ. of Illinois Medical Center, Chicago, II.
Concanavalin A-Sepharose (Con A-Sepharose), protein A-Sepharose, and CNBr­
Sepharose were from Pharmacia.
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3. Cell Free Synthesis of Rabbit SC
1.1 Introduction.
As discussed in Chapter 1, SC appears to have a dual character. It
serves first as a pIg receptor at the basolateral surface of the epithelial
cell, and, like other receptors, could be expected to be an integral mem-
brane protein. Later, when released into the lumen in association with
pIg, it is a soluble, secretory protein.
Only these latter secreted forms of SC have been isolated and charac­
terized from various secretions. The earlier biosynthetic forms of SC have
not been identified. Because characterization of these forms of SC can be
expected to hold the key for an understanding of its dual character and its
complex intracellular pathway, we investigated the earliest steps in SC
synthesis. Using translation of mRNA from rabbit mammary gland or liver in
a cell-free system supplemented with dog pancreas microsomal membranes, we
discovered that the translation products of SC include at least four dis­
tinct polypeptides. More importantly, these early biosynthetic forms of SC
are not synthesized as secretory proteins but as considerably larger
transmembrane proteins. The mature secretory forms of SC therefore are
proteolytic fragments derived from the transmembrane proteins.
1.� Results
Characterization of SC-Related Primary Translation Products. Mature
SC isolated from rabbit milk is heterogeneous. Depending on the individual
rabbit of the same strain, two or three polypeptides that differ in ap-
parent Mr by a few thousand can be resolved by SDS-PAGE (22). In the gel
system used in this study, the mature SC forms migrated with an apparent Mr
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of about 70,000 (Fig. 2, lane 1).
To compare these mature forms to the primary translation products, we
translated mRNA from rabbit mammary glands in the wheat germ cell-free sys­
tem. We used [35S]cysteine as the labeled amino acid because SC is particu-
larly rich in cysteine. Surprisingly, immunoprecipitation yielded four po-
lypeptide chains (Fig. 2, lane 2). Moreover, two of these four polypep-
tides (referred to as the upper doublet) had an apparent M of about 90,000
r
and therefore are about 20 kilodaltons larger than mature SC. The other two
bands (referred to as the lower doublet) were similar in mobility to the
mature SC bands. All four of these cell-free synthesized polypeptides were
immunologically related to the antigen because their immunoprecipitation
was effectively blocked when carried out in the presence of unlabeled ma-
ture SC (Fig. 2, lane 7).
In analogy to the heterogeneity of mature SC from different rabbits,
we also observed heterogeneity in the size of the translation products of
mRNAs derived from different rabbits. mRNA from rabbit B yielded a less-
well resolved upper doublet than did mRNA from rabbit A (Fig. 2, lanes 3
and 2, respectively). Moreover, the lower doublet from rabbit B appeared
to be unresolved. Evidence in favor of an unresolved doublet rather than a
single band is presented below.
The question, then, is: Are all four immunoprecipitated bands primary
translation products and are they related to the mature SC forms, or is the
observed size heterogeneity an artifact of irnmunoprecipitation or cell-free
synthesis?
To investigate whether this heterogeneity was due to a contaminant(s)
in the immunoprecipitation, we translated mRNA from liver, an organ that
also synthesizes SC. Because the total translation products of liver
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differ from those of mammary gland, one might also expect differences in
the pattern of the immunoprecipitated bands from liver if any of the four
bands were contaminants. However, translation of mRNA (from rabbit B) of
mammary gland (Fig. 3, lane 1) and of liver (Fig. 3, lane 2) yielded ident­
ical patterns of immunoprecipitated products.
To investigate whether the lower doublet might represent an artifact
of cell-free synthesis (due to degraded mRNAs or proteolysis of the upper
doublet) we size-fractionated poly(A)-containing mRNA from mammary gland of
rabbit B on sucrose gradients (Fig. 4). Our finding that the mRNAs coding
for the lower doublet migrated slower (Fig.4, fractions 10-14) than those
coding for the upper doublet (Fig. 4, fractions 8-12) argues strongly that
the lower doublet is not derived proteolytically from the upper doublet.
Furthermore, because the mRNAs have poly(A) at their 3' ends and presumably
have intact initiation sites at their 5' ends, the lower doublet is unlike­
ly to be the result of degraded mRNAs coding for the upper doublet.
Characterization of SC forms Translocated in the Cell-Free System into
Dog Pancreas Microsomal Vesicles. Cell-free translation of mRNAs for se­
cretory and transmembrane glycoproteins in the presence of dog pancreas mi­
crosomal membranes has been shown to reproduce with fidelity the in vivo
events that are coupled to the cotranslational translocation of the po­
lypeptide across the membrane (56). These events include core glycosyla­
tion at the cisternal side of the RER membrane (57-62). The cell-free
translocated forms of secretory and transmembrane proteins thus appear to
be analogous to the forms found in vivo in the cisternae of the RER. Be­
cause the mature forms of SC are glycoproteins, translation of mRNA in the
wheat germ cell-free system supplemented with dog pancreas microsomal vesi­
cles yielded core-glycosylated bands that moved slower than their counter-
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parts synthesized in the absence of membranes (Fig. 2, lane 5). That these
slower moving bands were in fact core-glycosylated was shown by their
specific binding to Con A-Sepharose (Fig. 5, lane 1). A small population
of chains was not glycosylated by the microsomal vesicles and did not bind
to Con A-Sepharose (Fig. 5, lane 2). This binding was inhibited in the
presence of alpha-methyl mannoside [Fig. 5, compare lane 3 (the material
bound in the presence of alpha-methyl mannoside) to lane 4 (the material
not bound in the presence of alpha-methyl mannoside)].
Similar observations were made with the SC-related chains synthesized
in the membrane-supplemented system using liver mRNA from rabbit B.
Although there was a shift-up of bands for the upper doublet (Fig. 3, lane
3), the banding pattern was complex, probably due to the presence of a sig­
nificant amount of unglycosylated chains. Interestingly, there was a
clearly resolved lower doublet (Fig. 3, lane 3) in which both bands had a
slower mobility than what appeared to be a single band for the correspond­
ing primary translation products (Fig. 3 lane 2). Our tentative interpre­
tation of these data was that in rabbit B the two primary translation pro­
ducts of the lower doublet were of similar size and thus comigrated,
whereas the core-glycosylated counterparts differed in mobility, perhaps
due to differences in the number of core-glycosylated asparagine residues.
As in the case of previously studied secretory glycoproteins, we ex­
pected that the various cell-free translocated forms of SC would be segre­
gated within the lumen of the dog pancreas microsomal vesicles and thus
completely protected from externally added proteases. Surprisingly, this
was not the case. A distinct portion of all four of the cell-free translo­
cated forms of SC was accessible to digestion by externally added trypsin,
and a distinct portion remained protected (see Fig. 2, lane 6, for rabbit
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A, and Fig. 3, lane 4, for rabbit B).
Protection was dependent on the integrity of the microsomal vesicles
because it was abolished when trypsin digestion was performed in the pres­
ence of detergents (Fig. 2, lane 9 and Fig. 3, lane 7). Moreover, when
synthesized in the absence of membranes, the primary translation products
were completely degraded even after a post translational incubation with mi­
crosomal vesicles (Fig. 2, lane 8 and Fig. 3, lane 6), suggesting that
translocation cannot occur after translation is completed.
We have not, however, conclusively determined the origin of each of
the protected fragments (Fig. 2, lane 6 and Fig. 3, lane 4) from their
respective intact counterparts (Fig. 2, lane 5 and Fig. 3, lane 3).
These proteolysis data indicate that each of the four forms of SC con­
tains an approximately 15-kilodalton portion that remains untranslocated by
the dog pancreas microsomal membranes and is therefore accessible to exter­
nally added trypsin. The most important conclusion that can be drawn from
these data, therefore, is that the various forms of SC are synthesized not
as secretory glycoproteins, but as transmembrane glycoproteins.
Cell-Free Translocated SC Forms are Competent to Bind IgA. It is
known that rabbit SC will bind specifically to human polymeric IgA (63).
We investigated whether cell-free synthesized and translocated rabbit SC
was competent to bind human IgA coupled to Sepharose (IgA-Sepharose). Dog
pancreas microsomal vesicles into which SC and other proteins had been
translocated were reisolated from the translation mixture by centrifugation
through a sucrose gradient. Among the total products that sedimented with
the microsomal membranes, the various forms of SC amounted to minor species
(Fig. 6, lane 1). The isolated membranes were solubilized with Triton X-
100 and incubated with IgA-Sepharose. These IgA-Sepharose beads were then
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washed and the bound proteins were eluted with SDS and analyzed by SDS-PAGE
and fluorography (Fig. 6, lane 2). The four SC forms became clearly discer­
nible because they are selectively enriched relative to the other bound po­
lypeptides. Moreover, only the binding of the four SC bands was specifi­
cally blocked by the addition of excess IgA (Fig. 6, lane 3) or SC (Fig. 6,
lane 4), indicating that all four of the SC bands were bound specifically
and that the other bands were bound non-specifically.
We also found that a considerable amount of SC did not bind to the
IgA-Sepharose beads and could be immunoprecipitated from the supernatant
(Fig. 6, lane 5). We do not know why only a fraction of the SC forms could
be bound, albeit specifically, to IgA. It is possible that the competence
to bind was not acquired by all molecules (due to improper folding) or that
it was lost after detergent solubilization.
1.1 Discussion
Prior to the cell-free synthesis studies presented here, SC from rab­
bit was believed to be genetically and biochemically heterogeneous. Two
allotypes of rabbit SC have been detected (64). Two or three immunologi­
cally related glycoproteins, slightly different in size and charge, have
been isolated from rabbit milk (22). Moreover, a number of smaller forms of
SC were immunoprecipitated from rabbit milk and were presumed to be degra­
dation products.
Our data indicate that the primary translation products of rabbit SC
consist of four polypeptides, distinct in size but immunologically related
to each other. Each of the four polypeptides was shown to be translocated
into dog pancreas microsomal vesicles by the criterion of being core­
glycosylated. However, translocation occurred only for a specific segment
--�-----...._
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of each of the four polypeptide chains, leaving another distinct segment
untranslocated and accessible to externally added trypsin. The untranslo­
cated portion amounted to 15 kilodaltons for each of the four chains.
Thus, the four SC forms are synthesized not as secretory proteins but as
transmembrane proteins.
How are the four cell-free synthesized transmembrane forms related to
the secreted forms in milk? Our data tentatively suggest the following re­
lationship. When integrated into dog pancreas microsomal vesicles, the
upper transmembrane doublet is tryptically digested to membrane-protected
fragments (Fig. 2, lane 6) that still migrate slower than the polypeptides
comprising mature SC (Fig. 2, lane 1). The somewhat smaller size of mature
secreted SC can be rationalized if one assumes (Fig. 1) that it is generat­
ed by proteolytic cleavage at the ectoplasmic side of the plasma membrane
(corresponding to the cisternal side of the RER). In contrast, the cell­
free generated, membrane-protected fragments are cleaved at the cytoplasmic
side of the membrane and therefore contain, in addition, the membrane­
spanning portions which are absent from the mature, secreted forms. Hence,
we propose that the upper doublet bands are the biosynthetic, transmembrane
precursors to the Mr-70,OOO secreted forms of SC. That the secreted forms
from some rabbits can be resolved into three bands (Fig. 2, lane 1) may
represent heterogeneity generated by posttranslational events. On the oth­
er hand, we cannot rule out that the upper doublet is made up of more than
two primary translation products that are not resolved.
What, then are the "mature" counterparts of the lower doublet
transmembrane forms? Again, if proteolytic cleavage also occurs for these
forms, then the secreted counterparts may be represented by the smaller
forms of SC that have been detected in milk, and that hitherto have been
-27-




Cell-free translation and transmembrane integration of rabbit mammary SC.
Lane 1 is a Coomassie blue-stained gel of authentic rabbit milk SC.
The remaining lanes are from a fluorograph of cell-free synthesized and im­
munoprecipitated products. Lanes: 2, mammary mRNA from rabbit A translat­
ed in the wheat germ sY,stem; 3, as in 2, except the mRNA was from rabbit B;
4, as in 2,. except that, after translation was completed (90 min incubation
at 250C) , dog pancreas microsomal vesicles were added and the incubation
continued for an additional 90 min; 5, as in 2, except that the microsomal
vesicles were present at the start of translation (all four bands are
shifted upward, due to cotranslational glycosylation by the membranes); 6,
as in 5, except that, after translation was completed, trypsin was added to
the reaction [all four bands are apparently shifted downward by about 15
kilodaltons; each of the two bands of the upper doublet appears to give
rise to two closely spaced bands, which could be due to the presence of two
nearby tryptic sites of which only one is cleaved in any given molecule
(other explanations are possible)]; 7, as in 2, except that irnrnunoprecipi­
tation was carried out in the presence of 1 ug of the SC shown in lane 1
(the added SC completely blocked immunoprecipitation of all four bands); 8,
as in 4, except that trypsin was added after translation was completed (be­
cause membranes were added after translation, the in vitro synthesized pro­
teins were not translocated and were digested by trypsin); 9, as in 6, ex­
cept that, when trypsin was added, the sample was also adjusted to 1S in
Triton X-IOO (even though the proteins were translocated, they were degrad­
ed when the microsomal vesicles were solubilized by detergent). The posi­
tions of the Mr marker proteins are indicated at the left margin, shown as
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Mr x 10-3 (rabbit muscle phosphorylase B, 92,000;
bovine serum albumin,




Cell-free translation and transmembrane integration of liver SC.
Lanes: 1, as in lane 3 of Fig. 2 (to give the positions of the mammary
SC bands of rabbit B); 2, liver mRNA from rabbit B translated in the wheat
germ system; 3, as in 2, except that dog pancreas microsomal vesicles were
present during translation; 4, as in 3, except that the sample was treated
with trypsin after translation; 5, as in 2, except that immunoprecipitation
was performed in the presence of 1 ug of SCi 6, as in 2, except that, after
translation, microsomal vesicles were added and the incubation was contin­
ued for go min before the sample was treated with trypsin; 7, as in 4, ex­




Partial fractionation of mRNA'� coding for se.
Po1y(A)-containing mRNA from rabbit B was fractionated on a sucrose
gradient. Twenty-two fractions were collected and the mRNA from every
second fraction was translated. In vitro synthesized products were immu­
noprecipitated and analyzed. The top of the gradient is toward the right.
Only selected fractions are presented. The fraction number from which each
lane is derived is indicated at the top of each lane. Lane T is an immu­
noprecipitate of a translation of total po1y(A)-containing mRNA. The upper
doublet is indicated by open arrowheads; the lower, unresolved, doublet, by
closed arrowheads. Note that fraction 8 is enriched for the upper doublet
whereas fraction 14 is enriched for the unresolved lower doublet. The
faint band beneath the unresolved lower doublet in fractions 10 and 12
probably is a contaminant.
T 6 10 12 14 16
Figure 5.
Cell-free synthesized SC are core glycosylated by dog pancreas microsomal
vesicles.
The newly synthesized chains (made in the presence of microsomal vesi­
cles) were separated into (i) bound (lane 1) or not bound (lane 2) to Con
A-Sepharose, and (ii) bound (lane 3) or not bound (lane 4) to Con A­
Sepharose in the presence of 0.4 M alpha-methyl mannoside which blocks
specific binding to the lectin. Binding of cell-free synthesized products




In vitro translocated SC forms � competent to bind human polymeric l!!.
Translations (100 ul) were performed in the presence of microsomal
vesicles. After translation was completed, membranes were recovered from
the translation mixture by layering it in a Beckman Airfuge tube over a two
step sucrose gradient consisting of 80 ul of 0.5 M sucrose and 25 ul of 2.0
M sucrose. Both sucrose solutions also contained 150 mM NaCl and 20 mM Na
phosphate (pH 6.5). After centrifugation for 15 min at 160,000 x g, mem­
branes were recovered at the 0.5/2.0 M interface in a volume of 25 ul.
They were diluted to 200 ul with 150 mM NaCl/20mM Na phosphate, pH 6.5, and
adjusted to l� in Triton X-IOO. A 2 ul aliquot of this was analyzed in
lane 1. This lane, therefore, represents 1� of the total in vitro syn­
thesized products which cosedimented with the membranes. IgA-Sepharose (20
ul) was added to the 198 ul of solubilized membranes and the samples were
agitated for 16 hr at 4oC. The beads were then washed five times with 1.2
ml of l� Triton X-IOOI 150 mM NaCl/20 �M Na phosphate, pH 6.5. Bound pro­
teins were eluted by boiling in loading buffer, and the sample analyzed by
electrophoresis and fluorography (lane 2; arrowheads as in Fig. 2, lane 2).
Other lanes: 3, as in 2, except that 10 ug of IgA, not bound to Sepharose,
was added at the same time as the IgA-Sepharose; 4, as in 2, except that 20
ug of SC was added at the same time as the IgA-Sepharose; 5, the material
that did not bind to IgA-Sepharose (i.e. the supernatant from the IgA­
Sepharose incubation) was adjusted to pH 8.1 and immunoprecipitated without
prior denaturation with SDS.
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4. Synthesis of SC by the Human Cell Line, HT29.EIO
4.1 Introduction.
In the previous chapter, we found that in a cell-free translation sys­
tem (supplemented with dog pancreas microsomal membranes) rabbit SC was
synthesized not as a secretory protein, but as a much larger transmembrane
protein. Larger, amphiphilic forms of SC were subsequently isolated from
rabbit liver and mammary gland (65). We therefore proposed that the por­
tion of the transmembrane protein exposed on the outside of the cell (the
ectoplasmic domain) binds pIg, while the membrane spanning and cytoplasmic
portions of the protein constitute the effector domain mediating tran­
scytosis. The secreted form of SC found in association with pIg in glandu­
lar secretions is therefore the proteolytically severed ectoplasmic domain
of this transmembrane receptor, cleaved sometime after the initiation of
transcytosis.
We extended our cell-free translation experiments from rabbit to human
SC, as the latter contains only one type of polypeptide chain, rather than
the four types found in rabbit. Moreover, we carried out in vivo pulse
and pulse-chase experiments, using a human adenocarcinoma-derived cell line
(HT29) that is known to synthesize SC (11, 38) and transport SC and pIg in
the "normal" manner (23). These in vivo experiments were facilitated by
our isolation of a clone, HT29.EIO, which produced SC in significantly
larger quantities than the parent cell line. The various in vitro and in
vivo synthesized forms of SC were characterized by using proteolytic en­
zymes as probes for their membrane orientation, by endoglycosidase H diges-
tion, and by partial NH2-terminal sequence analysis. Our data permitted us
to relate the forms of SC synthesized in vivo to their in vitro synthesized
1·
counterparts and permitted reconstruction of some of the events in the
biosynthetic pathway of SC.
Our results demonstrate (i) that human SC (M = 77,000) is synthesized
r
as a larger transmembrane precursor (Mr= 95,000) both in vivo and in vitro
and (ii) that SC found in secretions represents a proteolytically severed
fragment of this transmembrane precursor derived from its ectoplasmic
domain and containing its NH2-terminus.
4.2 Results
Cell-free translation and membrane integration of SC. Our first ob-
jective was to investigate whether human SC is synthesized as a larger
transmembrane form. We followed the same experimental protocol that had
been used in our previous study of rabbit SC. mRNA extracted from HT29.E10
cells was translated in the wheat germ cell-free system. The products were
immunoprecipitated with affinity purified antibodies to human SC and
analyzed by SDS-PAGE and fluorography. We found a single product of ap-
parent M -r- 80,000 (Fig. 7, lane 3) which was about 3 kilodaltons larger
than authentic SC from human colostrum (Fig. 7, lane 1, upper band). A con-
trol immunoprecipitate with non immune serum yielded a blank lane (Fig. 7,
lane 2).
Integration of a transmembrane protein into the rough endoplasmic re-
ticulum membrane, cleavage of its signal peptide, and core glycosylation
can be faithfully reproduced in the cell-free system by including rough mi-
crosomal vesicles from dog pancreas in the translation reaction (56). When
such microsomes were present during translation of HT29.EIO mRNA the M =
r
80,000 primary translation product was in part converted to several slower
moving bands, the largest of which had an apparent M =95,000 (Fig. 7, laner
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4, downward pOinting arrow) and to a slightly faster moving band (upward
pointing arrow in Fig 7, lane 4). By analogy to our data with rabbit SC
(16) and other precedents (57, 66) we presumed that these additional bands
represented membrane integrated polypeptides that were either fully core-
glycosylated (Fig 7, lane 4, downward pointing arrow), partially
glycosylated (Fig. 7, lane 4, dots), or unglycosylated (Fig. 7, lane 4, up-
ward pointing arrow). Our conjecture that the Mr= 95,000 band represented
a fully core-glycosylated form was based on its comigration with an in vivo
synthesized counterpart detected after a 5 min (Fig. 8, lane 1) or 30 min
(Fig. 7, lane 8 and Fig. 8, lane 2) labelling of cells (see below). Note
that partially or non-glycosylated forms were not detected in vivo. We
presumed that the fastest moving band (Fig 7, lane 4, upward pointing ar-
row) was a membrane integrated and signal peptide cleaved, but non-
glycosylated form.
We demonstrated that the products were cotranslationally integrated
into the dog pancreas microsomal membranes in a transmembrane configuration
by post-translational incubation with trypsin (Fig. 7, lane 5). Each of
the intact, membrane-integrated polypeptides (Fig. 7, lane 4) appeared to
be degraded to a corresponding membrane-protected fragment (Fig. 7, lane
5) reduced in size by about 15 kilodaltons. (The bands of the proteolytic
fragments of the partially and non-glycosylated forms were very faint and
do not photograph well). Thus, each of the membrane-integrated polypep-
tides appeared to contain a trypsin-accessible domain of nearly identical
mass. The resistance of these fragments to further trypsin digestion was
not an intrinsic property, but depended on the integrity of the membrane:
Post-translational incubation with trypsin in the presence of Triton X-IOO
resulted in their complete degradation (Fig. 7, lane 6). Moreover, in-
tegration was coupled to translation: When microsomal membranes were added
to the translation mixture after translation was completed, (Fig. 7, lane
7), the products were completely digested. These results showed that human
SC, like its rabbit counterpart, is synthesized in a cell-free system as a
larger form that can be cotranslationally integrated into dog pancreas mi-
crosomal membranes in a transmembrane configuration.
In vivo pulse chase experiments. These experiments were carried out
with the cloned human colon adenocarcinoma-derived cell line, HT29.EIO (see
Chapter 2) grown to confluency and forming a polarized epithelial monolayer
(23). Thus, the basolateral surface where transcytosis would be initiated
faces the plastic of the culture dish, whereas the apical surface is ex-
posed to the medium. Because of intracellular tight junctions pIg, which
might be introduced into the medium by the fetal bovine serum, would prob-
ably not have direct access to the basolateral surface. However, it is
likely that transcytosis can occur constitutively in the absence of the
ligand (pIg), as suggested by in vivo studies with rat liver: during perfu­
sion with pIg-free medium, SC continues to be released into the bile (67).
Pulse-labelling of these cells for 5 min (Fig. 8, lane 1) or for 30
min (Fig. 7, lane 8, and Fig. 8, lane 2) yielded a form of SC (M = 95,000)r
that is indistinguishable in apparent Mr from the fully glycosylated, mem­
brane integrated form synthesized in vitro (Fig. 7, compare lane 4, down-
ward pointing arrow, with lane 8).
To demonstrate that the pulse-labeled M = 95,000 form (like its in vi-r ---
tro synthesized counterpart) existed in a transmembrane orientation, we
subjected a homogenate of pulse-labeled cells to digestion with pronase
(Fig. 9). It can be seen that the pulse-labeled Mr= 95,000 form was re-
duced in mass by about 15 kilodaltons [Fig. 9, compare lanes 1 (not incu-
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bated) and 2 (incubated without pronase) with lane 3 (pronase-incubated)].
This is similar to the reduction in mass of the in vitro synthesized coun-
terpart by trypsin (see Fig. 1, lanes 4 and 5). The resistance of the
remainder of the molecule to further degradation by pronase was dependent
on the integrity of the membrane, since complete degradation occurred in
the presence of pronase and Triton X-IOO [Fig. 9, compare lane 4 (incubated
with Triton X-IOO alone) with lane 5 (incubated with Triton X-IOO plus
pronase) i,
Labelling for 30 min, followed by chases for periods ranging from
0.5-48 hr ( Fig. 1, lane 9, and Fig. 8, lanes 3-10) yielded a still larger
form of SC (M = 100,000). Moreover, as early as after a one hour chase,r
(Fig. 8, lane 4, upward pointing arrow), though more clearly after a 2 hr
chase (Fig. 8, lane 5), a Mr=80,OOO form appeared. This M = 80,000 formr
increased in amount at the expense of the M = 100,000 form at chaser
periods of up to 24 hr (Fig. 8, lanes 4-9). This Mr= 80,000 form also ap­
peared in the medium (Fig. 1, lane 10, and Fig. 8, lanes 13-18). It was
soluble and not merely released by shedding of membrane fragments, since it
resisted pelleting in a 30 min centrifugation in the Beckman airfuge at
160,000 x g, conditions which should pellet a 22 S particle (data not
shown) • The amount of Mr= 80,000 form associated with cells was higher
than the amount in the medium, at least during the shorter chase periods
[Fig. 8, compare 24 hr chased cells (lane 9) with the corresponding medium
(lane 11)]. Only at the longest chase period of 48 hr was the M _r- 80,000
form predominantly in the medium rather than associated with the cells
[Fig. 8, compare 48 hr chased cells (lane 12) with corresponding medium
(lane 18)].
Taken together, the in vivo pulse and pulse-chase experiments showed
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(i) that the earliest in vivo synthesized M = 95,000 form was indistin-
-- ---- r
guishable from the in vitro synthesized, membrane integrated, and fully
core-glycosylated form; (ii) that this M = 95,000 form is further converted
r
within a period of 1-2 hr to a Mr= 100,000 form, presumably by conversion
of the high-mannose core oligosaccharide moieties to the complex type (see
below); (iii) that the Mr= 100,000 form is converted to a Mr= 80,000 form
over a long period (2-48 hr); and (iv) that this M = 80,000 form isr
released into the medium from a cell-associated pool. These data suggest
that constitutive transcytosis occurs in these cells and that the released
Mr= 80,000 form of SC is proteolytically severed from the ectoplasmic
domain of the Mr= 100,000 transmembrane form (see below).
The Mr= 80,000 form released into the medium is still somewhat larger
than mature SC from human colostrum (Fig. 7, compare lanes 10 and 1,
respectively). This may be due to cleavage at a different site on the ec-
toplasmic domain of the precursor in the mammary gland as opposed to the
colon cancer cell line. Differences in the size of the cleaved form of SC
have been observed in comparing liver and mammary SC from rabbits (65).
Furthermore, the SC isolated from colostrum may have undergone a further
trimming of its carbohydrate chains or a secondary proteolytic cleavage,
since free colostral SC is rapidly degraded in vivo (68). Indeed, in the
pulse-chase experiment the broad Mr= 80,000 band migrated somehwat faster
after long chase times (Fig. 8, lanes 10 and 18).
Endoglycosidase � digestion. Endoglycosidase H digestion was carried
out on the intracellular early and late forms as well as on the secreted
form. Only the early intracellular form was affected by endoglycosidase H
treatment, resulting in a reduction of apparent M from 95,000 to 80,000r
[Fig. 7, compare control (lane 8) with endoglycosidase H-treated (lane
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11)]. The later intracellular forms (24 hr chase) as well as the form
secreted during this chase were all resistant to endoglycosidase H [Fig. 1,
compare controls (lanes 9 and 10, respectively) and endoglycosidase H
treated (lanes 12 and 13, respectively)]. This suggests that the conver-
sion of the Mr= 95,000 form to the Mr= 100,000 form was due to the process­
ing of high-mannose core oligosaccharides to the complex type (69).
Partial NH2-terminal sequence analysis. If our conjecture is correct
that secreted SC represents the ectoplasmic domain of the transmembrane
form and, moreover, if the ectoplasmic domain contains the NH2-terminus of
the transmembrane form, then the intracellular forms of SC and the form
released into the medium, as well as the membrane-protected fragment of SC
generated by pronase digestion of the pulse-labeled cell homogenate, would
be expected to have the same NH2-terminal sequence as SC isolated from
glandular secretions. That this is indeed the case is borne out by the
data in Fig. 10. We carried out partial NH2-terminal sequence analysis of
(i) the pulse-labeled M =
r
90,000 form (panel A); (ii) the membrane-
protected fragment generated by pronase digestion of the pulse-labeled form
in homogenized cells (panel B); (iii) the biosynthetically later M =r
100,000 form (panel C); (iv) the intracellular Mr= 80,000 cleavage product
of the M = 100,000 form (panel D); and (v) the secreted Mr= 80,000 cleavager
product of the M = 100,000 form (panel E). Of the NH2-terminal residuesr
analyzed, Pro occurs in all of the forms in positions 3 and 1. Further-
more, in the 30 min pulse form (Mr= 95,000) lIe occurs in position 4 (panel
F). (We did not label the other forms with lIe). This partial sequence
aligns with the known NH2-terminal sequence of human SC isolated from
colostrum, which has Pro in positions 3 and 1, and lIe in position 4 (10).
�.1 Discussion
The most generally significant result of our combined in vitro and in
vivo studies on the biosynthesis of human SC is the demonstration of a
precursor-product relationship between an integral membrane protein and a
secreted protein. While our previous studies on cell-free synthesis and
membrane integration of rabbit SC suggested such a relationship, our data
on human SC provided definitive evidence. By partial NH2-terminal sequence
analysis we documented that human SC is a proteolytically derived fragment
which represents most, if not all, of the ectoplasmic domain of a transmem-
brane protein precursor (Mr= 100,000), including the intact NH2-terminus.
Cleavage of the transmembrane precursor to generate secreted SC is a late
event. The protease(s) responsible for generating SC from its transmem-
brane precursor is not known. The fate of the remainder (about 15 kilodal-
tons) of the transmembrane precursor (the transmembrane segment(s) and
cytoplasmic domain) is unknown; most likely it is rapidly degraded.
Taken together with our earlier finding that the transmembrane precur-
sor of rabbit SC can bind IgA, our data strongly support our previous pro-
posal that this transmembrane precursor of SC is the receptor for tran-
scytosis of pIg. Thi� single polypeptide chain contains both functional
domains expected of such a receptor: an ectoplasmic ligand binding domain
and a cytoplasmic effector domain, which may be involved in mediating tran-
scytosis. However, it is possible that the transmembrane precursor of SC
constitutes only a part of the pIg receptor and that other, yet unidenti-
fied polypeptides are components of this receptor as well. The high affin-
ity binding sites for SC found on mammary cell membranes (22) may represent
such a protein(s).
Although we have no data on the subcellular localization of the vari-
.p � t.l.w..� , Ia. j
ous forms of SC, we can make some speculative correlations of our biosyn-
thetic data presented here with the pathway of SC and pIg observed cyto-
chemically. The early M = 95.000 form probably resides in the endoplasmicr
reticulum (7). since it contains unprocessed oligosaccharides and comi-
grates with the form inserted into dog pancreas microsomal membranes in vi-
tro. Processing to the terminally glycosylated Mr= 100,000 form presumably
takes places in the Golgi apparatus (21), where the appropriate enzymes
are located. Most likely, it is this Mr= 100.000 form that goes to the
basolateral (or in hepatocytes. sinusoidal) surface of the cell, binds pIg.
and is internalized. We do not know were cleavage to the M = 80.000 formr
takes place: The two most likely possibilities are in the transcytotic
vesicle or at the apical (or in hepatocytes. bile canalicular) surface fol-
lowing exocytosis. It is possible that a second cleavage event occurs in
certain tissues, since colostral SC is slightly smaller than the SC
released by the HT29.E10 cells. Nevertheless. it is clear from our se-
quence data that the cleavage(s) remove material exclusively from the
COOH-terminal portion of the precursor. as the precursor has the same NH2-
terminus as colostral SC.
We were surprised at both the slow rate of cleavage of the M = 100.000r
form to the Mr= 80.000 form. as well as the slow release of the Mr= 80.000
form into the medium. In vivo. transport of pIg across liver cells occurs
as rapidly as 10 min. although peak transport takes at least an hour (10.
13. 16, 19). Our experiments were done with transformed cells in culture
which probably do not process and transport SC as rapidly as do cells in
vivo. Although it appears that transport and processing of SC continues
constitutively [i.e. in the absence of the pIg ligand (67)], binding of the
ligand to the receptor at the basolateral surface may accelerate this pro-
n ...........W1 ..
cess. Furthermore, it is possible that after exocytosis and cleavage of
the SC precursor, the SC-plg complex normally remains bound to the apical
surface of the cell for a period. The high affinity binding sites for SC
found on mammary cells (22) may be responsible for this. A further, unk­




Comparison of SC synthesized in cell-free translations with SC made by
HT29.ElO cells.
Lane 1 is a Coomasie blue stained gel of human colostral secretory 19A
(Cappel). SC is the upper band. The lower band is the heavy chain of 19A.
Lanes 2-7 are immunoprecipitated products from cell-free translations of
HT29.ElO mRNA. Lanes 2 and 3 are from translations carried out in the ab­
sence of microsomal membranes. Lane 2: lmmunoprecipitation with preimmune
serum. Lanes 3-7: lmmunoprecipitations with affinity-purified antibodies
to SC. Lane 4: Translation performed in the presence of microsomal vesi­
cles. Downward-pointing arrow indicates fully core-glycosylated SC precur­
sor. Dots indicate partially glycosylated SC precursor. Upward-pointing
arrow indicates minor amount of SC precursor which probably has had it sig-
nal sequence removed but has not been glycosylated. Lane 5: Translation
performed in the presence of microsomal vesicles and post-translationally
digested with trypsin (0.1 mg/ml, 1 hr, OoC). Downward-pointing arrow in­
dicates protected fragment generated from fully core-glycosylated form.
Dots indicate very faint protected fragments probably generated from par­
tially glycosylated forms. Upward-pointing arrow indicates very faint
fragment probably generated from non-glycosylated, but membrane integrated
and signal sequence-cleaved form. Lane 6: Microsomal vesicles were added
only after completion of translation. The reaction was then digested with
trypsin as in lane 5. Lane 7: Translation was performed in the presence
of microsomal vesicles. The vesicles were post-translationaly solubilized
by adding Triton X-IOO to IS and then the sample was trypsinized as in lane
5. Lanes 8-13 are anti-SC immunoprecipitates of products synthesized by
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HT29.EIO cells during a pulse-chase experiment as described in Figure 2.
(The samples run in lanes 8, 9, and 10 are duplicates of those Fig. 8,
lanes 2, 9 and 17, respectively, and are provided here for comparison.)
Lane 8: Immunoprecipitate from cells labeled for 30 min. Lane 9: Immu-
noprecipitate from cells labeled for 30 min and then chased for 24 hr.
Lane 10: Immunoprecipitate from the chase medium of the cells in lane 9.
Lanes 11-13 are duplicates of the samples in lanes 8-10, respectively, ex-
cept that the immunoprecipitated products were treated with endoglycosidase
H prior to SDS-PAGE. Lanes 2-13 are aligned from the same fluorographed
gel. The positions of the molecular weight marker proteins used are indi­
cated at the left margin as M x 10-3•
r
Markers used were: E. coli beta-
galactosidase, Mr=116,OOO; phosphorylase b, Mr=92,000; and bovine serum al­
bumin, M =68,000.r







Pulse-chase analysis of SC synthesis and processing.
Cells were labeled with [35SJcysteine for either 5 min (lane 1) or 30
min (lanes 2-18). In lanes 3-18 after this labelling period the cells were
washed with PBS, the medium replaced with supplemented McCoy's 5a medium,
and the cells were chased for indicated times. Lanes 1-10 are anti-SC im­
munoprecipitates from the lysed cells. Lane 1: 5 min pulse. Lane 2: 30
min pulse. Lane 3: 30 min pulse, followed by 30 min chase. Lane 4: 1 hr
chase. Lane 5: 2 hr chase. Lane 6: 4 hr chase. Lane 7: 6 hr chase. Lane
8: 10 hr chase. Lane 9: 24 hr chase. Lane 10: 48 hr chase. Lanes 11 and
12 are preimmune serum immunoprecipitates from cells pulsed for 30 min
(lane 11) or pulsed for 30 min and chased for 48 hr (lane 12). Lanes 13-18
are anti-SC immunoprecipitates from the chase medium of cells which were
labeled for 30 min and then chased for indicated times. Lane 13: 2 hr
chase. Lane 14: 4 hr chase. Lane 15: 6 hr chase. Lane 16: 10 hr
chase. Lane 17: 24 hr chase. Lane 18: 48 hr chase. The lanes in this
figure were aligned from a 2 week exposure of one fluorographed gel.














Transmembrane orientation of SC synthesized by HT29.EIO cells. Cells
were pulse-labeled for 30 min. Lane 1: Immunoprecipitate of cells which
were not homogenized. Lane 2: Cells were homogenized after labelling and
then incubated on ice for I hr without additions. Lane 3: Incubation was
performed in the presence of 0.02 mg/ml pronase. Lane 4: Incubation was
performed in the presence of 0.4� Triton X-IOO. Lane 5: Incubation was
performed in the presence of both pronase and Triton X-IOO.
1 2 3 4 5
116-





Partial NH2-terminal sequence analysis of the various forms of SC.
Cells were labeled with either r3H]proline (panels A-E) or
r3H]isoleucine (panel F). Panels A and F are the Mr=95,000 pulse-labeled
form. Panel B is the protected fragment generated by pronase digestion of
pulse-labeled, homogenized cells. Panel C is the M =100,000 form associat­r
ed with cells after 24 hr of chase. Panel D is the Mr=80,000 form associ­
ated with cells after 24 hr of chase. Panel E is the Mr=80,OOO form
released into the medium after 24 hr of chase. The data presented are ra-
dioactivity (uncorrected cpm) released at each sequencer cycle. Arrows in-
dicate peaks corresponding to residues in SC from colostrum. The peak in
panel B, sequencer cycle', is probably due to wash out of material from
































5. Cloning and Sequencing of DNA Complementary to SC mRNA
5.1 Introduction.
In the two previous chapters, we described our finding that SC is made
as a transmembrane precursor, which is proteolytically cleaved to yield ma­
ture SC. We proposed that this precursor is the cell surface pIg receptor,
and that after transcellular transport, its ectoplasmic pIg binding domain
is cleaved and is discharged bound to pIg. The precursor has a large cyto­
plasmic domain (about 11-15 kilodaltons). This domain may interact with
cytoplasmic elements and provide the information for guiding the SC through
the cell, first to the basolateral surface, and then via endocytosis,
transcytosis, and finally exocytosis at the apical (or in liver, bile
canalicular) surface.
As a first step towards understanding the mechanism of this protein
transport process, we cloned and sequenced cDNA for SC mRNA and deduced the
primary structure of the COOH terminal 163 amino acids of the transmembrane
precursor, comprising its cytoplasmic and membrane spanning portions. The
membrane spanning segment consists of 23 non-charged, predominantly hydro­
phobic amino acids, and is followed by a presumably cytoplasmically exposed
hydrophilic segment of 103 amino acids.
5.2 Results
We have previously shown that rabbit SC comprises four primary trans-
lation products: an upper doublet of Mr =90-93,000, and a poorly resolved
lower doublet of Mr =10-11,000.
We partially purified the mRNA coding for the upper doublet of SC by
size separation of total poly(A) containing RNA from rabbit lactating mam-
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mary gland on a sucrose gradient. This mRNA was converted to double­
stranded cDNA by standard procedures, and the cDNA inserted into the
plasmid PBR 322 by G-C tailing. The plasmids containing the cDNA inserts
were transformed into the E. coli strain MCI061. Approximately 600 tetra­
cycline resistant, ampicillin sensitive clones were obtained. Eighteen of
these clones were initially screened by the ability of their plasmid DNA to
specifically select mRNA coding for secretory component. The first plasmid
so identified contained an insert of approximately 700 base pairs. It was
used as a hybridization probe to screen the remaining clones. Twelve
clones were found in this manner. The clone designated p32.23 contained the
largest insert (approximately 1650 base pairs, including G-C tails) and was
the only clone studied in further detail. The DNA of p32.23 specifically
selected mRNA for each of the SC primary translation products from both
liver (Fig. 11, lane 4) and mammary (Fig. 11, lane 7) mRNAs suggesting that
these proteins are coded for by mRNAs which are very similar, at least in
the region complementary to the sequence in p32.23. However, since the
mRNA used for cloning was highly enriched in species coding for the upper
doublet, it is likely that we have cloned the cDNA derived from mRNA coding
for one of the polypeptides of this doublet.
To further characterize these mRNAs, we separated total liver and mam­
mary mRNAs by forma1dehyde-agarose gel electrophoresis, transferred the
mRNAs to nitrocellulose paper, and hybridized with nick translated p32.23.
Two broad bands, corresponding in size to an estimated 4200 and 3600 base
pairs were found in both liver (Fig. 12, lane 1) and mammary (Fig. 12, lane
2) mRNAs. Each band may represent the two unresolved mRNAs coding for the
corresponding protein doublet.
Our principal objective in this study was to deduce the primary struc-
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ture of the cytoplasmic and membrane spanning portions of the SC precursor.
We have previously shown by direct protein sequencing that these portions
are located at the carboxy-terminal region of the molecule, and therefore
should be coded for by the 3' part of the coding region of the mRNA. Since
the cDNA clones were constructed by priming from the 3' po1y(A) tail, it
seemed likely that that p32.23 would represent the 3' portion of the mRNA.
We therefore sequenced the insert in p32.23 by randomly subcloning frag-
ments produced with several restriction enzymes into the phages M13 Mp8 and
M13 Mp9 and then using the dideoxy chain termination method. The strategy
used for sequencing is shown in Fig. 13 and the complete sequence in Fig.
14. The insert in p32.23 contains 1563 base pairs, plus a poly(A) tail at
the 3' end and G-C tails at both ends. Note that the sequence contains the
unusual po1y(A) addition sequence AUUAAA located 20-25 residues from the
po1y(A) tail. This po1y(A) addition sequence has so far been found only
in lysozyme (71) and mouse pancreatic amylase (72) mRNAs.
Computer-assisted sequence analysis indicated that there was only one
Significant open reading frame, which extends from the 5' end of the se-
quence to nucleotide 489. The corresponding protein sequence is indicated
in Fig. 4. This reading frame codes for 163 amino acids which constitute
the carboxy-terminal end of the SC precursor. The remaining portion of the
SC precursor would then be coded for by sequences which are not contained
in this clone. The relationship between the mRNA, the cDNA insert in
p32.23, and the deduced protein sequence is indicated in Fig. 15. Our data
indicates that the SC mRNA contains an unusually large 3' untranslated re-
gion of 1074 bases. Since the primary translation product of the SC precur­
sor has a M =90-93,000, we would expect that the coding region of the mRNAr
would contain about 3,000 bases. Since the mRNA is about 4,200 bases long
-59-
and 1074 bases are in the 3' untranslated region, it can be estimated the
5' untranslated region is about 125 bases long.
To test whether we made the correct reading frame assignment, we
translated SC mRNA in the cell free system in the presence of
[35S]methionine, isolated the M =90,000 product by immunoprecipitation andr
SDS-polyacrylamide gel electrophoresis, digested it with trYPsin, and sub-
jected the total mixture of tryptic peptides to automated Edman degrada-
tion. The cleaved form of rabbit SC contains little or no methionine (73),
so most or all methionine labeled tryptic peptides will be derived from
either the carboxy-terminal extension of the precursor or a putative signal
peptide. Three peaks of radioactivity were released at cycles 5, 12, and
18 (Fig. 16). The peaks at cycles 5 and 18 would result from peptides pro-
duced by cleavage after arginine at position 77, and lysine at position 37,
respectively, and thus support our reading frame assignment. There are
three possible explanations for the peak at cycle 12. First, there could be
a methionine in a putative signal sequence. Second, there could be a
methionine in the secreted form of SC. Third, because the carboxy-terminal
sequence of the cleaved SC form is not yet known, we do not know at what
position the cleavage of the SC precursor occurs; it is possible that this
cleavage occurs in a region amino-terminal to that coded for by the se-
quences in p32.23. Hence, the methionine released in position 12 may be
located between the COOH-terminus of mature SC and the sequence represent-
ed in p32.23.
�.l Discussion.
The most striking feature of the sequence is a stretch of 23 un-
charged, predominantly non-polar amino acids (amino acids 38-60), preceded
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by a lysine (residue 37), and followed immediately by the basic sequence
Arg-Ala-Arg-His-Arg (amino acids 61-66). These features are typical of
membrane spanning segments from a variety of transmembrane proteins (74-
79). It has been proposed that most membrane spanning segments are in an
alpha-helical configuration (74, 78). Residues 46 to 60 certainly could be
in such a structure. However, residue 45 is a proline, which is a strong
helix breaker (81). [Proline has in fact been found in the membrane span­
ning segments of bacteriorhodopsin (92)]. These results suggest, but do
not prove, that amino acids 38 to 60 constitute the membrane-spanning seg­
ment of the SC precursor. However, we cannot rule out that the precursor
contains other membrane spanning segments that are further upstream and
coded for by sequences not contained in p32.23. in clone 32.23.
The proposed cytoplasmic domain consists of 103 predominantly hydro­
philic amino acids with a total molecular weight of 11,120. This is rea­
sonably consistent with our previous estimate that about 15 kilodaltons at
the carboxy-terminus of the SC precursor could be digested by proteases
acting at the cytoplasmic surface of the membrane. The proteolysis data
did not indicate whether this portion of the molecule might loop back into
the lipid bilayer, or if it were a soluble, globular domain. The abundance
of charged residues (16 basic residues and 20 acidic residues) as well as
uncharged but hydrophilic residues (6 asparagines and glutamines, and 14
threonines and serines) suggests that this COOH-terminal portion of the
molecule is indeed soluble. However, residues 140-154 contain no charged




Translation of mRNAs selected by hybridization to p32.23 DNA.
Hybridization-selection, translation, immunoprecipitation, and product
analysis were performed as described in Chapter 2. In lane 1, translation
products of unfractionated rabbit liver mRNA (from rabbit B) were immu­
noprecipitated with goat antiserum to rabbit secretory IgA. This antiserum
immunoprecipitates the same SC translation products as the antiserum used
in Chapter 3. The bands around Mr =90-93,000 and Mr =10,000 are the pri­
mary translation products of SC. Lanes 2-4 were from translation of mRNAs
selected by hybridization of total rabbit liver RNA to plasmid DNAs immo­
bilized on nitrocellulose filters. Lane 2 was a control for specificity of
hybridization in which PBR 322 DNA was immobilized on the filter and the
translation products of the selected mRNAs were immunoprecipitated with an­
tiserum to rabbit secretory IgA. Lane 3 was a control for specificity of
immunoprecipitation in which the translation products of mRNAs selected by
p32.23 were immunoprecipitated with non-immune goat serum. In lane 4 the
products of mRNAs selected by hybridization to p32.23 DNA were immunopre­
cipitated by antiserum to rabbit secretory IgA. In lane 5-1 the same ex­
periments were performed as in lanes 2-4, respectively, except that total









Analysis of SC mRNAs.
As described in Chapter 2, 1 ug of total poly(A)-containing mRNA from
either liver (lane 1) or lactating mammary (lane 2) was fractionated on an
agarose-formaldehyde gel, transferred to nitrocellulose, and probed with
nick translated p32.23. The positions of the l8S and 28S ribosomal RNA






Restriction map and sequencing strategy of p32.23 insert DNA.
The scale at the top is in nucleotides. Only restriction sites used
in the sequence analysis are shown. The G-C tails at both ends of the in­
sert are indicated by \/\. Restriction fragments produced by the indicated
enzymes were shotgun subcloned into M13 Mp8 or Mp9. Subclones were picked
at random and sequenced. Arrows indicate direction and extent of sequenc­
ing of each subclone. The subclone indicated at the bottom line contained
the entire insert, including G-C tails. We sequenced through the G-C tail
at the 5' end of this clone by substituting reverse transcriptase for the
Klenow fragment of DNA polymerase 1.
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DNA sequence of insert in p32.23 and translation into amino acid sequence
-----
of the carboxy-terminus of SC precursor.
Numbering of the nucleotide sequence is indicated on the left margin
and numbering of the amino acid sequence is indicated on the right margin.
The polyadenylation signal sequence at nucleotides 1538-1543 is indicated
by overlining. The amino acid sequence of the putative membrane spanning
segment (residues 38-60) is printed in lower case, while the remaining ami-
no acids are in upper case. The proposed cytoplasmic domain was analyzed
by the secondary structure prediction scheme of Chou and Fasman (81).
Predictions are depicted as follows: alpha helix is underlined by a
straight line, beta sheet by a wavy line, and beta turns by a dotted line.
We wish to emphasize that these predictions are only probabilistic and that




CCT CGG CTC CTT GCG GAG GAG GTA GCA GTG CAG AGT GCG GAA GAC CCA GCC AGT GGG AGC
PRO ARG LEU LEU ALA GLU GLU VAL ALA VAL GLN SER ALA GLU ASP PRO ALA SER GLY SER 20
61 AGA GCG TCT GTG GAT GCC AGC AGT GCT TCG GGA CAA AGC GGG AGT GCC AAA GTA CTG ATC
ARG ALA SER VAL ASP ALA SER SER ALA SER GLY GLN SER GLY SER ALA LYS val leu ile 40
121 TCC ACC CTG GTG CCC TTG GGG CTG GTG CTG GCA GCG GGG GCC ATG GCC GTG GCC ATA GCC
ser thr leu val pro leu gly leu val leu ala ala gly ala met ala val ala ile ala 60
181 AGA GCC CGG CAC AGG AGG AAC GTG GAC CGA GTT TCC ATC GGA'AGC TAC AGG ACA GAC ATT
ARG ALA ARG HIS ARG ARG ASN VAL ASP ARG VAL SER ILE GLY SER TYR ARG THR ASP ILE 80
241 AGC ATG TCA GAC TTG GAG AAC TCC AGG GAG TTC GGA GCC ATT GAC AAC CCA AGC GCC TGC
SER HET SER ASP LEU GLU ASN SER ARG GLU PHE GLY ALA ILE ASP ASN PRO SER ALA CYS 100
301 CCC GAT GCC CGG GAG ACG GCC CTC GGA GGA AAG GAT GAG TTA GCG ACG GCC ACC GAG AGC
PRO ASP ALA ARG GLU THR ALA LEU GLY GLY LYS ASP GLU LEU ALA THR ALA THR GLU SER 120
............... 1'/
361 ACC GTG GAG ATT GAG GAG CCC AAG AAG GCA AAA CGG TCA TCC AAG GAA GAA GCC GAC CTG
THR VAL GLU ILE GLU GLU PRO LYS LYS ALA LYS ARG SER SER LYS GLU GLU ALA ASP LEU 140
�------------------------------------------------------
421 GCC TAC TCA GCT TTC CTG CTC CAA TCC AAC ACC ATA GCT GCT GAG CAC CAA GAT GGC CCC
ALA TYR SER ALA PHE LEU LEU GLN SER ASN THR ILE ALA ALA GLU HIS GLN ASP GLY PRO 160
- .
481 AAG GAG GCC TAG GCA CAG CCG GCC ACC GCC GCC GCC GCC ACC GCC GCC GCC GCC GCC ACC
LYS GLU ALA stop
541 TGT GAA AAT CAC CTT CCA GAA TCA CGT TGA TCC TCG GGG TCC CCA GAG CCG GGG GCT CAA
601 CCG CCC TGC ACC CCC CAT GTC CCC ACC ACC TAA ACT TCC CTA CCT GTG CCC AGA GGT GTG
661 CTG GTC CCC TCC TCC ACG GCA TCC AGG CCT GGC TCA ATG TTC CCG TTG GGG TGG GGG TGT
121 GAG GGG TTC CTA CTT GCA GCC CGG TTC TCC CGA GAG AAG CTA AGG ATC CAG GTC CTG AGG
181 GAG GGG CCT CTC GAA GGC AGA CAG ACC AGA GAG GGG GGA GGA GCC CTT GGA TGG GAG GCC
841 AGA GGC GCT TTC CGG CCA CCC CCT CCC TCC CTG CCC CCA CCC TCC TTC CTT CAT TCA AAA
901 GTC CCA GTG GCT GCT GCC TAG GGT CCA GGC GCT GGC CGC ACG CCT CCT CGA AGC CGT TGT
961 GCA AAC ATC ACT GGA GGA AGC CAG GGC TCC TCC CGG GCT GTG TAT CCT CAC TCA GGC CTC
1021 CTG TCC TCC CCA GTA TCA GGA GAT GTC AAG CGT CTG AAG GCT GTG TGC CCT GGG CGT GTC
1081 TGC AAG TCA CCC CAG ACA CAT GTT CTC GCC ATT TTA CAG ATG AGA ACA CTG AGG TTG TAC
1141 TCA AGG GCA CCC TGC GAG ATG GAG CAA CAG CAl AGT AGA TGG GCT TCT GCT GTC CTC TTG
1201 GCC AGA GGT CTC TCC ACA GGA GCC CCT GCC CCT GTA GGA AGC AGA GTT TTA GAA CAT GGA
1261 AGA AGA AGA GGG GGA TGG CCC TGG ACG CTG ACC TCT CCC AAG CCC CCA CGG GGG AAA AGG
1321 CCC CCT CCT TTT CTG TCA CTC TCG GGG ACC TGC GGA GTT GAG CAT TCG TGC CCC GTG TGT
1381 CTG AAG AGT TCC CAG TGG AAA GAA GAA AAG AGG GTG TTT GTC AGT GCC GGG GAG GGC CTG
1481 ATC CCC AGA CAG CTG AAG TTT AAG GTC CTT GTC CCT GTG AGC TTT AAC CAG CAC CTC CGG




Partial amino acid sequence analysis of cell-free synthesized SC.
SC was translated in vitro using [35S]methionine as the labeled amino
acid. The Mr =90,000 band was purified by immunoprecipitation and SDS-
polyacrylamide gel electrophoresis. This protein was digested with tryp­
sin, and the total mixture of tryptic peptides was subjected to automated
Edman degradation. The data presented are radioactivity released at each
sequencer cycle. The low apparent repetitive yield is probably due to
washout of the short peptides from the sequencer cup. In particular, the
peptide producing the peak of radioactivity in cycle 18 is derived from am­
ino acids 38-61; this peptide is unusually hydrophobic and is probably very










Proposed relationship of SC mRNA, cDNA cloned in EE.23, and SC.
SC mRNA is depicted at the top, the cDNA cloned in p32.23 in the mid­
dle, and the SC precursor at the bottom. The figure represents one of the
Mr =90-93,000 SC precursor molecules and its corresponding mRNA. Numbers
above the mRNA and the cDNA indicate number of nucleotides. Numbers fol­
lowed by "aa" below the SC protein indicate number of amino acids. The
proposed cytoplasmic domain of SC is indicated by cross-hatching and the
membrane spanning segment by a solid bar. The estimates of the number of
nucleotides in the SC mRNA, and especially of the number of amino acids in
the precursor and secreted forms of SC are only approximate. Consequently,
the estimate of the size of the 5' untranslated region of the mRNA is very
inexact.
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The central findings of this work are (i) that SC is made as a larger
transmembrane precursor which has a sizable (11-15 kilodaltons) cytoplasm­
ic, COOH-terminal domain. and (ii) that SC found in secretions is a proteo­
lytic fragment of this precursor. derived from its ectoplasmic, pIg binding
domain and containing its NH2-terminus. These findings provide the protein
structural basis for how SC can function first as a membrane receptor for
pIg at the basolateral surface of the epithelial cell and later be a solu­
ble. secreted protein.
Our data provide strong support for our proposed pathway of SC and pIg
in the cell (Fig. 1): SC is made on the RER as a transmembrane protein with
an 11-15 kilodalton portion remaining untranslocated across the membrane
and thus exposed in the cytoplasm. The precursor passes through the Golgi
apparatus. It then reaches the basolateral surface, where its ectoplasmic
domain can bind pIg. We cannot rule out the possibility that the transmem­
brane precursor goes initially to both apical and basolateral surfaces and
then is sorted to the basolateral surface, either via diffusion in the
plane of the plasma membrane or via vesicular transport. The SC molecule,
bound to pIg, is endocytosed and the endocytotic vesicle travels across the
cell and is exocytosed at the apical surface. At some point, the ecto­
plasmic domain is proteolytically cleaved from the remainder of the
molecule.
Several aspects of this model are unsettled. First, we have not
directly localized any of these forms in the cell. On the basis of the
cell-free membrane integration studies and by analogy to other membrane
glycoproteins, the high-mannose form produced first in the cell-labelling
experiments is probably in the RER. Similarly, the processing of the oli-
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gosaccharides to the complex type probably occurs in the Golgi apparatus.
However, we have not directly demonstrated that the transmembrane precursor
is actually found on the basolateral surface of the cell. More important­
ly, we do not know where cleavage of the precursor occurs. Cleavage before
endocytosis at the basolateral surface is unlikely, since otherwise SC
could diffuse into the extracellular fluid and SC is not normally found in
plasma. Our pulse-chase data in colon cancer cells indicated that the
cleaved form of SC is found associated with the cells long before it is
released into the media and this suggests that cleavage occurs inside the
endocytotic vesicle. Alternatively, cleavage might occur after exocytosis
and the cleaved SC could remain bound to the apical surface. However,
cytochemically SC is not detected at the apical cell surface of these colon
cancer-derived cells (23). In liver, on the other hand, SC and IgA are
detected bound to the bile canalicular surface (18) and it is possible that
cleavage in liver occurs after exocytosis.
Second, we do not know what becomes of the membrane-spanning and cyto­
plasmic portions of the precursor after cleavage. Our antibodies were
raised against SC from secretions and we therefore do not have a handle on
the remainder of the molecule. Presumably it is rapidly degraded.
Third, we do not know why rabbit SC is heterogeneous. All of the
forms are transmembrane proteins with similarly sized cytoplasmic domains
and all can bind pIg. Humans have only one form of SC, so the heterogenei­
ty in rabbits may be unessential.
Fourth, although it appears that transcytosis and processing of SC may
occur even in the absence of its ligand, pIg, the process may be accelerat­
ed by the binding of ligand at the basolateral surface. Isolated rat liver
perfused in the absence of pIg continues to secrete SC in the bile (61).
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Humans deficient in IgA have free SC in their secretions, although in this
case, IgM substitutes for IgA (15).
We must also consider additional functions for SC. SC has long been
thought to protect IgA from proteolytic degradation in secretions (82). In
the case of the human genetic variant of IgA, IgA2 A2rn(1) [formerly desig­
nated AM2(+)], which lacks heavy chain-light chain disulfide bridges, the
SC also stabilizes the molecule against dissociation (83). SC might also
serve to bind pIg to another receptor. Such a receptor might be present on
the apical surface of duct rather than acinar cells and thus would function
in keeping much of the externally exposed glandular epithelial surfaces
coated with pIg. In fact, after it has been transported by hepatocytes,
IgA seems to remain associated with biliary epithelium (18). Furthermore,
the binding sites for SC found in rabbit mammary cells may represent bind­
ing to tubular cells and not the membranes of acinar cells (22).
Several aspects of the pathway of SC make it of general interest in
studying sorting during intracellular protein traffic. In receptor mediat­
ed endocytosis (24,25) the receptor protein must localize in clathrin coat­
ed pits on the plasma membrane, and then after endocytosis travel one of
several pathways, such as recycling to the plasma membrane, degradation in
the lysosome, or transcellular transport (84). In the rat hepatocyte, for
instance, the IgA-SC precursor complex and the asialoglycoprotein receptor
are endocytosed in the same coated pit and are initially in the same endo­
cytotic vesicle (85). (Presumably, SC and other receptors are similarly en­
docytosed together in liver and other tissues.) Yet, after endocytosis in a
common vesicle, the various receptors and ligands follow different path­
ways: The asialoglycoprotein receptor recycles to the plasma membrane; its
ligand dissociates from the receptor and is delivered to lysosomes and de-
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graded; SC and pIg are transcytosed and discharged into bile. [Apparently,
in a competing process, IgA can also bind to and be taken up by the asialo­
glycoprotein receptor (86)].
Polarized epithelial cells also face the problem of directing proteins
to the appropriate cell surface. Certain viruses, for example, bud only
from one cell surface or the other (87). The pathway for SC is unusual in
that it moves first to the basolateral surface and then to the apical.
The precursor of SC is unique among receptors in that it is cleaved
and its ectoplasmic domain is discharged with the ligand. It is possible
that SC is continually inserted, endocytosed, and reinserted into both sur­
faces of the cell at random and that the unidirectionality of the transport
process is established by the protease which cleaves the precursor being
localized to the apical surface. However, it would be difficult to account
for the speed and efficiency of pIg transport by this model. Furthermore,
at least in colon cells, cleavage probably occurs in the endocytotic vesi­
cle. Finally, this stochastic model does not account for how the differ­
ences in composition of the two surfaces are maintained.
We know very little about the mechanisms which direct membrane pro­
teins to their appropriate locations in the cell (91). In general we as­
sume that at least some steps in sorting occur by interaction of the mem­
brane protein with other protein(s) in the cytoplasm. This most likely oc­
curs via a direct interaction of the cytoplasmic tail of the membrane pro­
tein with these other cytoplasmic protein(s), although it might occur in­
directly via an intermediary transmembrane protein(s) which binds to some
other portion of the protein being transported. The information for sort­
ing may be contained in one or more sorting sequences or other discrete
structural features of the protein being sorted, which specify particular
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steps in the process (88).
We therefore determined the structure of the cytoplasmic tail of the
SC precursor and examined it for clues as to how it might function as an
effector domain for guiding the molecule through the cell. As discussed in
Chapter 5, except for residues 140-154, the cytoplasmic tail is very
charged and hydrophilic and thus probably does not loop into the lipid bi­
layer, but rather is a soluble domain in the cytoplasm.
We also compared this cytoplasmic tail with those of other transmem­
brane proteins. A number of proteins span the membrane several times and
contain large portion exposed on the cytoplasmic surface, such as the Ca+2
ATPase of sarcoplasmic reticulum (89), the acetylcholine receptor 66), and
the erythrocyte Band 3 (90). All of these proteins function in transport
of ions across the membrane and their substantial cytoplasmic domains may
be involved in this process. Their cytoplasmic domains may also be in­
volved in anchoring the proteins to the cytoskeleton, as in the case of
Band 3 (90).
The SC precursor, in contrast, probably spans the membrane only once,
although we cannot rule out that it spans the membrane several times. We
tabulated in Fig. 11 a representative selection of other plasma membrane
proteins which span the membrane once (14, 16-19). We included the only
other receptor involved in endocytosis which has been sequenced, i.e. the
chicken hepatic lectin, a receptor for clearance of N-acetyl-glucosamine­
terminated proteins from the plasma (15). Although it has not been se­
quenced, the receptor for endocytosis of transferrin was included, because
it has been shown by proteolysis to contain a cytoplasmic domain of about
five kilodaltons (80). The striking feature is that the SC precursor tail
is much larger than those of these other proteins. Furthermore, aside from
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the general cluster of basic residues immediately following the membrane
spanning segment, we discern no obvious sequence homology of the SC precur­
sor tail with these other tails.
In the absence of X-ray crystallographic data, we cannot definitively
compare the three-dimensional structure of these cytoplasmic domains. How­
ever, we did apply the empirical secondary structure prediction scheme of
Chou and Fasman (81), which is generally 70-80� accurate, to the various
tails depicted in Fig. 17. Aside from the SC precursor tail, the other
tails were predicted to have little alpha helix content, which is not
surprising in view of their small size. In contrast, the SC precursor tail
was predicted to be mostly alpha helix (56�), as depicted in Fig. 14.
Several stretches of beta sheet and beta turns were also predicted.
The large size and possible secondary structure of the tail of the SC
precursor offer a tantalizing glimpse into how it may function in guiding
the molecule through the cell. Since we have cloned DNA complementary to
the mRNA for this portion of the molecule, it may now be possible to use
recombinant DNA technology to analyze how this occurs.
-19-
Figure 11.
Comparison of cytoplasmic tails of selected proteins presumed to span the
plasma membrane �.
The sizes of the cytoplasmic tails are given in number of amino acids
and are drawn to scale. The ectoplasmic domains are not drawn to scale.
The locations of the amino and carboxy termini with respect to the lipid
bilayer are indicated by "N" and "C", respectively. Proteins are: SC,
membrane-bound IgM (18), mouse histocompatibility antigen H-2Kb (11), human
erythrocyte glycophorin (14), vesicular stomatitis glycoprotein, G (19),
semliki forest virus glycoprotein E1 (16), chicken hepatic lectin (15), and
transferrin receptor (80). (The transferrin receptor has not been se­
quenced. It is also not known where its amino and carboxy termini are lo­
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